August 25, 2023 Release Highlights Copied

08/25/20232023 VBCRelease note

Practice Insights is pleased to announce updates in the application to support the Merit-Based Incentive Payment System (MIPS) and Enhancing Oncology Model (EOM).

MIPS Quality Measures Dashboard

The dashboard has been updated to reflect the below refinement(s) for:

Measure	Update	Practice Impact
MIPS 226: Tobacco Screening and Cessation	The measure has been updated to reflect the following changes: Denominator Exclusion: Excluding patients in hospice care for any part of the measurement period. Denominator Exceptions have been removed for 2023. Population 2 The numerator evaluates patients receiving tobacco cessation intervention during the measurement period or in the six months prior to the measurement period. Population 3 The numerator evaluates patients who were screened for tobacco use at least once during the measurement period AND who received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period if identified as a tobacco user.	Practices will notice an impact in the numerator, denominator, and performance due to the specification updates. The updates will impact Population 2 the least which is the population scored by CMS.

Measure

Update

Practice Impact

MIPS 226: Tobacco Screening and Cessation

The measure has been updated to reflect the following changes:

Denominator Exclusion: Excluding patients in hospice care for any part of the measurement period.
Denominator Exceptions have been removed for 2023.

Population 2

The numerator evaluates patients receiving tobacco cessation intervention during the measurement period or in the six months prior to the measurement period.

Population 3

The numerator evaluates patients who were screened for tobacco use at least once during the measurement period AND who received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period if identified as a tobacco user.

Practices will notice an impact in the numerator, denominator, and performance due to the specification updates. The updates will impact Population 2 the least which is the population scored by CMS.

Dashboard Updates

To support practices participating in the Enhancing Oncology Model (EOM), we are introducing the EOM Eligibility Dashboard to identify patients for enrollment.

To support VBC programs, we are introducing the VBC Navigation Summary dashboard, which will replace the report practices received every Tuesday through SFTPs. It also summarizes EOM episodes for patients enrolled in the model.

EOM Eligibility Dashboard

This dashboard includes patients who have a scheduled encounter within the next 2 weeks or 1 week prior who have been on chemo or hormonal therapy in the past.

This dashboard’s main purpose is to provide a list of patients eligible for the EOM program that your practice can target for enrollment.

This dashboard also provides additional clinical information, such as patient diagnosis, chemo or hormone therapy names, hospice status, an end-stage renal disease flag, and primary and secondary payer information.

Use the filters across the top (callouts 1-5) to narrow down the search results by:

Practice Name
Division
Location
Provider
High Potential EOM Candidate

The dashboard will display the Patient Count based on your filters (callout 6). You may export this data by clicking the Export Patient Data button (callout 7).

This will open the Download Crosstab window. Select the Patient Data option (callout 8), choose your preferred document format (callout 9), and click the Download button (callout 10) to complete the data export.

NOTE: Choose the CSV format for the most optimal experience. If you choose Excel, save the file as a CSV to ensure the most accurate information.

VBC Navigation Summary Dashboard

The dashboard data is based on the VBC Care Plan in iKnowMed Generation 2. It will replace the report practices received every Tuesday through SFTPs. It will include VBC Programs documented in the VBC Care plan with the ability to filter by program.

In addition, this dashboard includes the following EOM information: episode, EOM PBPM fee, MEOS date of service, location, provider, diagnosis, episode start date, episode end date, billing date of service, billing fees, last modified, users, and comments.

Use the filters across the top (callouts 1-5) to narrow down the search results by:

Practice Name
Division
Location
Provider
VBC Program

The VBC Program option filters the table by the programs documented for your patients in iKnowMed Generation 2:

The dashboard will display patient-level details based on your filters. You may export this data by clicking the Export Patient Data button (callout 6).

This will open the Download Crosstab window. Select the Patient Data option (callout 7), choose your preferred document format (callout 8), and click the Download button (callout 9) to complete the data export.

NOTE: Choose the CSV format for the most optimal experience. If you choose Excel, save the file as a CSV to ensure the most accurate information.

Status of Dashboard Updates for 2023

CMS releases updates to the quality measure specifications annually for the MIPS program and bi-annually for the OCM program. These measure specifications have been reviewed, and Practice Insights is working on the required technical updates to align with the revised requirements. McKesson will continue to notify practices once measures have been updated based on the current 2023 requirements. The measures listed below either have no 2023 update required or have been updated.

Measure	Description
MIPS Quality Measures Dashboard
#047	Advance Care Plan
#104	Adjuvant Hormonal Therapy for High-Risk or Very High-Risk Prostate Cancer
#130	Current Medications Documentation
#134	Preventive Care Screening: Screening for Depression and Follow-Up Plan
#143	Pain Intensity Quantified
#144	Pain Care Plan
#226	Tobacco Screening and Cessation
#236	Controlling High Blood Pressure
#374	Closing the Referral Loop
#451	RAS (KRAS and NRAS) Gene Mutation Testing Performed for Patients with Metastatic Colorectal Cancer who Receive Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody Therapy
#452	Percentage of Adult Patients (aged 18 or older) with Metastatic Colorectal Cancer and RAS (KRAS & NRAS) Gene Mutation Spared Treatment with Anti-EGFR Monoclonal Antibodies
#457	Patients Admitted to Hospice for < 3 Days
PIMSH#1	Advance Care Planning in Stage 4 Disease
PIMSH#2	Utilization of GCSF in Metastatic Colon/Rectal Cancer (Inverse Measure)
PIMSH#4	Patient-Reported Pain Improvement
PIMSH#8	Mutation Testing for Lung Cancer
PIMSH#9	Supportive Care Drug Utilization in the Last 14 Days of Life (Inverse Measure)
PIMSH#10	Hepatitis B Serology Testing for Prophylactic Treatment Prior to Receiving Anti CD20 Targeting Drugs
PIMSH#15	Antiemetic Therapy for Low-and-Minimal-Emetic Risk Antineoplastic Agents in the Infusion Center-Avoidance of Overuse (Inverse Measure)
PIMSH#16	Appropriate Antiemetic Therapy for High-and Moderate-Emetic-Risk Antineoplastic Agents in the Infusion Center